Last updated on April 2018

RIC Regimen for Low- and Intermediate-risk MDS Receiving Haplo-HSCT


Are you eligible to participate in this study?

You may be eligible for this study if you meet the following criteria:

  • Conditions: Preleukemia | MYELODYSPLASTIC SYNDROME
  • Age: Between 1 - 70 Years
  • Gender: Male or Female

Inclusion Criteria:

  • Patients who had low- and intermediate-risk MDS without ISD nor URD receiving haploidentical hematopoietic stem cell transplantation

Exclusion Criteria:

  • Patients having ISD or URD; patients having high-risk MDS; patients with active infection; patients with poor compliance; patients with organ failure

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Volunteer Sign-up

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.